ESAB vs UTHR · P/E 27, rev $2.84B vs P/E 20, rev $1.56B
ESAB Corp (ESAB) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
ESAB Corp (ESAB) is a metal fabrication company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ESAB revenue for 2025-12-31 was $2.84B. Net income was $226.8M. Revenue was up 3.7% from 2024-12-31 to 2025-12-31. ESAB currently screens at market cap $7.88B and trailing P/E 26.6.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
ESAB currently screens at market cap $7.88B and trailing P/E 26.6. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the ESAB and UTHR stock pages for the full models.
Not investment advice.